MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity.

Authors:
Zhou S; Ling X; Zhu J; Liang Y; Feng Q and 17 more

Journal:
Theranostics

Publication Year: 2024

DOI:
10.7150/thno.92848

PMCID:
PMC10879875

PMID:
38389852

Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"transcriptomics data in this study has been uploaded to the ncbi sra database (accession number: prjna987376 prjna974908).; the metabolomics data in this study are available in the metabolights database (mtbls9333)."

Code Sharing
Evidence found in paper:

"Competing Interests: The authors have declared that no competing interest exists."

Evidence found in paper:

"This work was supported by National Natural Science Foundation of China Grant 82225010, 82070707, 82000652, 82100786; National Key R&D Program of China (2020YFC2005000); and Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (2019J013, 2021J001); and a Postdoctoral Science Foundation of China grant (2021M701636)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025